FDA — authorised 20 July 2011
- Application: NDA022433
- Marketing authorisation holder: ASTRAZENECA
- Status: supplemented
🇺🇸 Brilinta in United States
FDA authorised Brilinta on 20 July 2011
Marketing authorisations
FDA
- Status: approved
Brilinta in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United States
Frequently asked questions
Is Brilinta approved in United States?
Yes. FDA authorised it on 20 July 2011; FDA has authorised it.
Who is the marketing authorisation holder for Brilinta in United States?
ASTRAZENECA holds the US marketing authorisation.